MedTrace Logo

De-labeling of Patients With False Diagnosis of Penicillin Allergy

NCT03581604 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-11-03

No results posted yet for this study

Summary

The purpose of this study is to estimate the prevalence of penicillin allergy, evaluate the diagnostic value of the allergologic work-up used in the study, and the health effects of penicillin allergy.

Conditions

  • Allergy Drug

Interventions

DIAGNOSTIC_TEST

Allergy work-up

Allergy work-up

OTHER

Blood samples

Blood samples

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Eva Stylianou, Phd · Oslo University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-13
Primary Completion
2023-12-31
Completion
2026-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581604 on ClinicalTrials.gov